Still, data from human samples showed increased NLRP3 inflammasome levels in patients with severe NAFLD, in addition to the up-regulated Il-1β mRNA and its correlated Col1a1 mRNA [65]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.